Aerobit Health Limited

aerobithealth.com

There is a need for patients to remember to adhere with their treatments and keep doctors in the loop with critical data. Aerobit is platform of smart hardware and software making managing asthma easier and more effective than ever. Aerobit’s mission is to be at the epicenter of improving Asthma care through a revolution in digital healthcare. Aerobit is a digital health startup building an asthma care platform with a Smart Inhaler Device at the epicenter. Our aim is to improve the quality of life of millions of asthma sufferers in the UK and reduce the risk of unnecessary fatalities due to this common chronic disease.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMACY MARKET

PATSNAP UNVEILS SYNAPSE VISITOR, THE LATEST AI-POWERED PHARMACEUTICAL INTELLIGENCE PLATFORM

Prnewswire | April 25, 2023

news image

On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical organizations, now publicly accessible for the first time. Users can explore these features without prior registration, making searching easier and more accessible than ever before. Synapse is an innovative Life Sciences Pl...

Read More

Business Insights

GLAUKOS ANNOUNCES MORE THAN 1 MILLION ISTENT® TECHNOLOGIES IMPLANTED WORLDWIDE

Glaukos | September 12, 2022

news image

Glaukos Corporation an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases announced a significant milestone as its iStent® family of technologies have now been implanted in more than one million procedures worldwide. This market-leading milestone is a testament to the decades of investment from Glaukos as the corporate founder and pioneer of the now well-established micro-invasive glaucoma ...

Read More

PHARMACY MARKET, PHARMA TECH

SANOFI AND INNATE PHARMA EXPAND COLLABORATION FOR NATURAL KILLER CELL THERAPEUTICS IN ONCOLOGY

Sanofi and Innate Pharma | December 19, 2022

news image

Innate Pharma SA and Sanofi announced an expansion of their collaboration, with Sanofi licensing a natural killer cell engager program targeting B7H3 from Innate’s ANKETTM. Sanofi will also have the option to add up to two additional ANKETTM targets. Upon candidate selection, Sanofi will be responsible for all development, manufacturing and commercialization. Innate and Sanofi signed a first NK cell engagers collaboration in 2016 for the generation and evaluation of up to tw...

Read More

Business Insights

ELLIGO HEALTH RESEARCH® PARTNERS WITH PEOPLES RX

Elligo Health Research | April 21, 2022

news image

Elligo Health Research, the largest healthcare-enabling research organization, announced they are expanding partnerships to include Peoples Rx, an Austin, Texas-based pharmacy chain. “We’re in a unique position at Peoples Rx to help inform more people about how they can participate in clinical research opportunities. Working with Elligo to offer research as healthcare to our customers helps support our mission to empower people to make educated he...

Read More
news image

Business Insights, PHARMACY MARKET

PATSNAP UNVEILS SYNAPSE VISITOR, THE LATEST AI-POWERED PHARMACEUTICAL INTELLIGENCE PLATFORM

Prnewswire | April 25, 2023

On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical organizations, now publicly accessible for the first time. Users can explore these features without prior registration, making searching easier and more accessible than ever before. Synapse is an innovative Life Sciences Pl...

Read More
news image

Business Insights

GLAUKOS ANNOUNCES MORE THAN 1 MILLION ISTENT® TECHNOLOGIES IMPLANTED WORLDWIDE

Glaukos | September 12, 2022

Glaukos Corporation an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases announced a significant milestone as its iStent® family of technologies have now been implanted in more than one million procedures worldwide. This market-leading milestone is a testament to the decades of investment from Glaukos as the corporate founder and pioneer of the now well-established micro-invasive glaucoma ...

Read More
news image

PHARMACY MARKET, PHARMA TECH

SANOFI AND INNATE PHARMA EXPAND COLLABORATION FOR NATURAL KILLER CELL THERAPEUTICS IN ONCOLOGY

Sanofi and Innate Pharma | December 19, 2022

Innate Pharma SA and Sanofi announced an expansion of their collaboration, with Sanofi licensing a natural killer cell engager program targeting B7H3 from Innate’s ANKETTM. Sanofi will also have the option to add up to two additional ANKETTM targets. Upon candidate selection, Sanofi will be responsible for all development, manufacturing and commercialization. Innate and Sanofi signed a first NK cell engagers collaboration in 2016 for the generation and evaluation of up to tw...

Read More
news image

Business Insights

ELLIGO HEALTH RESEARCH® PARTNERS WITH PEOPLES RX

Elligo Health Research | April 21, 2022

Elligo Health Research, the largest healthcare-enabling research organization, announced they are expanding partnerships to include Peoples Rx, an Austin, Texas-based pharmacy chain. “We’re in a unique position at Peoples Rx to help inform more people about how they can participate in clinical research opportunities. Working with Elligo to offer research as healthcare to our customers helps support our mission to empower people to make educated he...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us